These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 26742522

  • 1. Clozapine Improves Memory Impairment and Reduces Aβ Level in the Tg-APPswe/PS1dE9 Mouse Model of Alzheimer's Disease.
    Choi Y, Jeong HJ, Liu QF, Oh ST, Koo BS, Kim Y, Chung IW, Kim YS, Jeon S.
    Mol Neurobiol; 2017 Jan; 54(1):450-460. PubMed ID: 26742522
    [Abstract] [Full Text] [Related]

  • 2. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Jeon S, Bose S, Hur J, Jun K, Kim YK, Cho KS, Koo BS.
    J Ethnopharmacol; 2011 Sep 01; 137(1):783-9. PubMed ID: 21762767
    [Abstract] [Full Text] [Related]

  • 3. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W, Hao J, Liu R, Zhang Z, Lei G, Su C, Miao J, Li Z.
    Behav Brain Res; 2011 Sep 23; 222(2):342-50. PubMed ID: 21513747
    [Abstract] [Full Text] [Related]

  • 4. Progressive Spatial Memory Impairment, Brain Amyloid Deposition and Changes in Serum Amyloid Levels as a Function of Age in APPswe/PS1dE9 Mice.
    Fu L, Sun Y, Guo Y, Yu B, Zhang H, Wu J, Yu X, Wu H, Kong W.
    Curr Alzheimer Res; 2018 Sep 23; 15(11):1053-1061. PubMed ID: 29984654
    [Abstract] [Full Text] [Related]

  • 5. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities.
    Savonenko A, Xu GM, Melnikova T, Morton JL, Gonzales V, Wong MP, Price DL, Tang F, Markowska AL, Borchelt DR.
    Neurobiol Dis; 2005 Apr 23; 18(3):602-17. PubMed ID: 15755686
    [Abstract] [Full Text] [Related]

  • 6. Biochemical and behavioral characterization of the double transgenic mouse model (APPswe/PS1dE9) of Alzheimer's disease.
    Xiong H, Callaghan D, Wodzinska J, Xu J, Premyslova M, Liu QY, Connelly J, Zhang W.
    Neurosci Bull; 2011 Aug 23; 27(4):221-32. PubMed ID: 21788993
    [Abstract] [Full Text] [Related]

  • 7. Illite improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer׳s disease through Akt/CREB and GSK-3β phosphorylation in the brain.
    Jeon S, Park JE, Lee J, Liu QF, Jeong HJ, Pak SC, Yi S, Kim MH, Kim CW, Park JK, Kim GW, Koo BS.
    J Ethnopharmacol; 2015 Feb 03; 160():69-77. PubMed ID: 25457987
    [Abstract] [Full Text] [Related]

  • 8. Changes in the brain and plasma Aβ peptide levels with age and its relationship with cognitive impairment in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Izco M, Martínez P, Corrales A, Fandos N, García S, Insua D, Montañes M, Pérez-Grijalba V, Rueda N, Vidal V, Martínez-Cué C, Pesini P, Sarasa M.
    Neuroscience; 2014 Mar 28; 263():269-79. PubMed ID: 24447596
    [Abstract] [Full Text] [Related]

  • 9. Recombinant soluble neprilysin reduces amyloid-beta accumulation and improves memory impairment in Alzheimer's disease mice.
    Park MH, Lee JK, Choi S, Ahn J, Jin HK, Park JS, Bae JS.
    Brain Res; 2013 Sep 05; 1529():113-24. PubMed ID: 23831521
    [Abstract] [Full Text] [Related]

  • 10. Neoline Improves Memory Impairment and Reduces Amyloid-β Level and Tau Phosphorylation Through AMPK Activation in the Mouse Alzheimer's Disease Model.
    Liu QF, Kanmani S, Lee J, Kim GW, Jeon S, Koo BS.
    J Alzheimers Dis; 2021 Sep 05; 81(2):507-516. PubMed ID: 33814448
    [Abstract] [Full Text] [Related]

  • 11. Overexpression of Ubiquilin-1 Alleviates Alzheimer's Disease-Caused Cognitive and Motor Deficits and Reduces Amyloid-β Accumulation in Mice.
    Adegoke OO, Qiao F, Liu Y, Longley K, Feng S, Wang H.
    J Alzheimers Dis; 2017 Sep 05; 59(2):575-590. PubMed ID: 28598849
    [Abstract] [Full Text] [Related]

  • 12. Hippocampal administration of chondroitinase ABC increases plaque-adjacent synaptic marker and diminishes amyloid burden in aged APPswe/PS1dE9 mice.
    Howell MD, Bailey LA, Cozart MA, Gannon BM, Gottschall PE.
    Acta Neuropathol Commun; 2015 Sep 04; 3():54. PubMed ID: 26337292
    [Abstract] [Full Text] [Related]

  • 13. The Effects of Cardiotrophin-1 on Early Synaptic Mitochondrial Dysfunction and Synaptic Pathology in APPswe/PS1dE9 Mice.
    Wang D, Liu X, Liu Y, Li S, Wang C.
    J Alzheimers Dis; 2017 Sep 04; 59(4):1255-1267. PubMed ID: 28731433
    [Abstract] [Full Text] [Related]

  • 14. Intermittent hypoxia treatment alleviates memory impairment in the 6-month-old APPswe/PS1dE9 mice and reduces amyloid beta accumulation and inflammation in the brain.
    Yue X, Zhou Y, Qiao M, Zhao X, Huang X, Zhao T, Cheng X, Fan M, Zhao Y, Chen R, Zhu L.
    Alzheimers Res Ther; 2021 Nov 29; 13(1):194. PubMed ID: 34844651
    [Abstract] [Full Text] [Related]

  • 15. Self-assembling nanofibers alter the processing of amyloid precursor protein in a transgenic mouse model of Alzheimer's disease.
    Yang H, Yang H, Xie Z, Wang P, Bi J.
    Neurol Res; 2015 Jan 29; 37(1):84-91. PubMed ID: 25005263
    [Abstract] [Full Text] [Related]

  • 16. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
    Gu XH, Xu LJ, Liu ZQ, Wei B, Yang YJ, Xu GG, Yin XP, Wang W.
    Behav Brain Res; 2016 Sep 15; 311():309-321. PubMed ID: 27233830
    [Abstract] [Full Text] [Related]

  • 17. S14G-humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice.
    Zhang W, Zhang W, Li Z, Hao J, Zhang Z, Liu L, Mao N, Miao J, Zhang L.
    Pharmacol Biochem Behav; 2012 Jan 15; 100(3):361-9. PubMed ID: 21993310
    [Abstract] [Full Text] [Related]

  • 18. Anti-Inflammatory Treatment with FTY720 Starting after Onset of Symptoms Reverses Synaptic Deficits in an AD Mouse Model.
    Kartalou GI, Salgueiro-Pereira AR, Endres T, Lesnikova A, Casarotto P, Pousinha P, Delanoe K, Edelmann E, Castrén E, Gottmann K, Marie H, Lessmann V.
    Int J Mol Sci; 2020 Nov 25; 21(23):. PubMed ID: 33255764
    [Abstract] [Full Text] [Related]

  • 19. A modified preparation (LMK03) of the oriental medicine Jangwonhwan reduces Abeta(1-42) level in the brain of Tg-APPswe/PS1dE9 mouse model of Alzheimer disease.
    Seo JS, Jung EY, Kim JH, Lyu YS, Han PL, Kang HW.
    J Ethnopharmacol; 2010 Aug 09; 130(3):578-85. PubMed ID: 20669372
    [Abstract] [Full Text] [Related]

  • 20. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
    Arendash GW, Schleif W, Rezai-Zadeh K, Jackson EK, Zacharia LC, Cracchiolo JR, Shippy D, Tan J.
    Neuroscience; 2006 Nov 03; 142(4):941-52. PubMed ID: 16938404
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.